LOIM
MDGL icon

Liberty One Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Liberty One Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-549
Closed -$147K – 186
2024
Q1 		$147K Sell
549
-3
-0.5% -$707 0.02% 143
2023
Q4 		$128K Buy
552
+34
+7% +$5.95K 0.02% 132
2023
Q3 		$75.6K Sell
518
-131
-20% -$24.7K 0.01% 131
2023
Q2 		$150K Sell
649
-980
-60% -$265K 0.02% 125
2023
Q1 		$395K Sell
1,629
-300
-16% -$81.7K 0.05% 109
2022
Q4 		$560K Hold
1,929
– – 0.08% 104
2022
Q3 		$125K Buy
1,929
+183
+10% +$12.7K 0.02% 130
2022
Q2 		$170K Sell
1,746
-171
-9% -$12.6K 0.03% 127
2022
Q1 		$188K Sell
1,917
-441
-19% -$37.2K 0.03% 126
2021
Q4 		$200K Buy
2,358
+639
+37% +$52.5K 0.03% 126
2021
Q3 		$137K Sell
1,719
-27
-2% -$2.33K 0.02% 135
2021
Q2 		$170K Buy
1,746
+394
+29% +$46.6K 0.03% 138
2021
Q1 		$158K Buy
1,352
+685
+103% +$79.9K 0.03% 133
2020
Q4 		$74K Buy
667
+232
+53% +$28.4K 0.01% 133
2020
Q3 		$52K Buy
435
+206
+90% +$22.4K 0.01% 130
2020
Q2 		$26K Buy
+229
New +$22.5K 0.01% 131

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Liberty One Investment Management's MDGL Position: Q2 2024 in Review

Liberty One Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2024, closing a stake of 549 shares — an estimated $147K sold.

Liberty One Investment Management first reported a position in MDGL in Q2 2020 and held it in 16 quarters. The position peaked at $560K in Q4 2022. 257 funds tracked by Wall St. Rank hold MDGL as of Q2 2024.

  • Liberty One Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Liberty One Investment Management sold 549 Madrigal Pharmaceuticals shares in Q2 2024, an estimated $147K.
  • Liberty One Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2020 and held it in 16 quarters.
  • Liberty One Investment Management's Madrigal Pharmaceuticals position peaked at $560K in Q4 2022.
  • 257 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2024.

Based on Liberty One Investment Management's 13F filing for Q2 2024, filed 22 Jul 2024.